"gene","module","V1","V3","Protein.names","Organism","Gene.Ontology..biological.process.","Gene.Ontology.IDs"
"FUN_002433","ME2","ntLink_8:1537514-1543906","F1LU71","Methylglutaconyl-CoA hydratase, mitochondrial (3-MG-CoA hydratase) (EC 4.2.1.18) (AU-specific RNA-binding enoyl-CoA hydratase) (AU-binding enoyl-CoA hydratase) (Itaconyl-CoA hydratase) (EC 4.2.1.56)","Rattus norvegicus (Rat)","fatty acid beta-oxidation [GO:0006635]; leucine catabolic process [GO:0006552]","GO:0003723; GO:0003730; GO:0004300; GO:0004490; GO:0005739; GO:0006552; GO:0006635; GO:0050011"
"FUN_004083","ME2","ntLink_8:18989336-18999141","Q9ET22","Dipeptidyl peptidase 2 (EC 3.4.14.2) (Dipeptidyl aminopeptidase II) (Dipeptidyl peptidase 7) (Dipeptidyl peptidase II) (DPP II) (Quiescent cell proline dipeptidase)","Mus musculus (Mouse)","lysosomal protein catabolic process [GO:1905146]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004177; GO:0005576; GO:0005764; GO:0005794; GO:0005829; GO:0006508; GO:0008236; GO:0008239; GO:0030163; GO:0031410; GO:0031982; GO:0043231; GO:1905146"
"FUN_004100","ME8","ntLink_8:19281646-19295845","Q32NH8","1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-4 (EC 3.1.4.11) (Phosphoinositide phospholipase C-delta-4) (Phospholipase C-delta-4) (PLC-delta-4)","Xenopus laevis (African clawed frog)","intracellular signal transduction [GO:0035556]; lipid catabolic process [GO:0016042]","GO:0004435; GO:0005509; GO:0005634; GO:0005783; GO:0016020; GO:0016042; GO:0035556"
"FUN_004270","ME13","ntLink_8:21410696-21416488","O35459","Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial (EC 5.3.3.-)","Mus musculus (Mouse)","fatty acid beta-oxidation [GO:0006635]","GO:0005739; GO:0005777; GO:0006635; GO:0051750"
"FUN_000632","ME8","ntLink_6:5217131-5219121","O97125","Heat shock protein 68","Drosophila melanogaster (Fruit fly)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to starvation [GO:0042594]; vesicle-mediated transport [GO:0016192]","GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008340; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0042594; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0140662"
"FUN_000637","ME8","ntLink_6:5244470-5246789","O97125","Heat shock protein 68","Drosophila melanogaster (Fruit fly)","cellular response to unfolded protein [GO:0034620]; chaperone cofactor-dependent protein refolding [GO:0051085]; determination of adult lifespan [GO:0008340]; protein refolding [GO:0042026]; response to starvation [GO:0042594]; vesicle-mediated transport [GO:0016192]","GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0005886; GO:0008340; GO:0016192; GO:0016887; GO:0031072; GO:0034620; GO:0042026; GO:0042594; GO:0044183; GO:0051082; GO:0051085; GO:0051787; GO:0140662"
"FUN_001040","ME0","ntLink_6:7563562-7571096","P80035","Gastric triacylglycerol lipase (GL) (Gastric lipase) (EC 3.1.1.3)","Canis lupus familiaris (Dog) (Canis familiaris)","lipid catabolic process [GO:0016042]","GO:0004806; GO:0005576; GO:0016042; GO:0043231"
"FUN_001160","ME1","ntLink_6:9221504-9231233","P97742","Carnitine O-palmitoyltransferase 1, liver isoform (CPT1-L) (EC 2.3.1.21) (Carnitine O-palmitoyltransferase I, liver isoform) (CPT I) (CPTI-L) (Carnitine palmitoyltransferase 1A)","Mus musculus (Mouse)","carnitine metabolic process [GO:0009437]; cellular response to fatty acid [GO:0071398]; eating behavior [GO:0042755]; epithelial cell differentiation [GO:0030855]; fatty acid beta-oxidation [GO:0006635]; fatty acid metabolic process [GO:0006631]; glucose metabolic process [GO:0006006]; lipid localization [GO:0010876]; liver regeneration [GO:0097421]; long-chain fatty acid metabolic process [GO:0001676]; positive regulation of fatty acid beta-oxidation [GO:0032000]; regulation of fatty acid oxidation [GO:0046320]; regulation of insulin secretion [GO:0050796]; regulation of lipid storage [GO:0010883]; response to alkaloid [GO:0043279]; response to antibiotic [GO:0046677]; response to ethanol [GO:0045471]; response to nutrient levels [GO:0031667]; response to organic cyclic compound [GO:0014070]; response to tetrachloromethane [GO:1904772]; response to xenobiotic stimulus [GO:0009410]; triglyceride metabolic process [GO:0006641]","GO:0001676; GO:0004095; GO:0005739; GO:0005741; GO:0005743; GO:0006006; GO:0006631; GO:0006635; GO:0006641; GO:0009410; GO:0009437; GO:0010876; GO:0010883; GO:0014070; GO:0016020; GO:0030855; GO:0031667; GO:0032000; GO:0042755; GO:0042802; GO:0043231; GO:0043279; GO:0045471; GO:0046320; GO:0046677; GO:0050796; GO:0071398; GO:0097421; GO:1904772; GO:1990698"
"FUN_001201","ME36","ntLink_6:9717132-9724304","Q4R4S5","Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","lipid catabolic process [GO:0016042]","GO:0004771; GO:0005764; GO:0016042"
"FUN_001205","ME0","ntLink_6:9770394-9775062","Q5VXJ0","Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","Homo sapiens (Human)","cornification [GO:0070268]; lipid catabolic process [GO:0016042]","GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268"
"FUN_001204","ME1","ntLink_6:9760494-9764836","Q5VXJ0","Lipase member K (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 2)","Homo sapiens (Human)","cornification [GO:0070268]; lipid catabolic process [GO:0016042]","GO:0004465; GO:0005576; GO:0016042; GO:0043231; GO:0070268"
"FUN_001326","ME1","ntLink_6:11156063-11157165","Q4R4S5","Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","lipid catabolic process [GO:0016042]","GO:0004771; GO:0005764; GO:0016042"
"FUN_001396","ME1","ntLink_6:11908587-11910717","O97562","Dicarboxylate carrier SLC25A8 (Mitochondrial uncoupling protein 2) (UCP 2) (Solute carrier family 25 member 8)","Sus scrofa (Pig)","adaptive thermogenesis [GO:1990845]; C4-dicarboxylate transport [GO:0015740]; cellular response to glucose stimulus [GO:0071333]; glutamine metabolic process [GO:0006541]; glycolytic process [GO:0006096]; macrophage differentiation [GO:0030225]; mitochondrial fission [GO:0000266]; mitochondrial transmembrane transport [GO:1990542]; mitochondrial transport [GO:0006839]; reactive oxygen species metabolic process [GO:0072593]; response to cold [GO:0009409]","GO:0000266; GO:0005743; GO:0006096; GO:0006541; GO:0006839; GO:0008271; GO:0009409; GO:0015078; GO:0015131; GO:0015140; GO:0015183; GO:0015297; GO:0015740; GO:0017077; GO:0022857; GO:0030225; GO:0042803; GO:0071333; GO:0072593; GO:0140787; GO:1990542; GO:1990845"
"FUN_005739","ME27","ptg000001l:3463186-3464035","A0A1L4BJ98","Dermonecrotic toxin Hl-PLD1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D)","Hemiscorpius lepturus (Scorpion)","hemolysis in another organism [GO:0044179]; lipid catabolic process [GO:0016042]","GO:0005576; GO:0008081; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729"
"FUN_005740","ME18","ptg000001l:3465741-3469633","A0A1L4BJ98","Dermonecrotic toxin Hl-PLD1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D)","Hemiscorpius lepturus (Scorpion)","hemolysis in another organism [GO:0044179]; lipid catabolic process [GO:0016042]","GO:0005576; GO:0008081; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729"
"FUN_005741","ME18","ptg000001l:3471331-3472428","A0A1L4BJ98","Dermonecrotic toxin Hl-PLD1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D)","Hemiscorpius lepturus (Scorpion)","hemolysis in another organism [GO:0044179]; lipid catabolic process [GO:0016042]","GO:0005576; GO:0008081; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729"
"FUN_005742","ME18","ptg000001l:3474126-3475223","A0A1L4BJ98","Dermonecrotic toxin Hl-PLD1 (EC 4.6.1.-) (Phospholipase D) (PLD) (Sphingomyelin phosphodiesterase D) (SMD) (SMase D) (Sphingomyelinase D)","Hemiscorpius lepturus (Scorpion)","hemolysis in another organism [GO:0044179]; lipid catabolic process [GO:0016042]","GO:0005576; GO:0008081; GO:0016042; GO:0016829; GO:0044179; GO:0046872; GO:0090729"
"FUN_007020","ME8","ptg000001l:19366430-19381367","Q32Q86","Cryptochrome-1","Rattus norvegicus (Rat)","circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; lipid storage [GO:0019915]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of glucocorticoid secretion [GO:2000850]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; regulation of gluconeogenesis [GO:0006111]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to insulin [GO:0032868]; response to light stimulus [GO:0009416]; selective autophagy [GO:0061912]; signal transduction in response to DNA damage [GO:0042770]","GO:0000122; GO:0003677; GO:0003690; GO:0005634; GO:0005737; GO:0005739; GO:0006094; GO:0006111; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0016922; GO:0019900; GO:0019901; GO:0019902; GO:0019915; GO:0031397; GO:0031398; GO:0032868; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0042770; GO:0042826; GO:0043153; GO:0045721; GO:0045722; GO:0045744; GO:0045892; GO:0061912; GO:0070888; GO:0071949; GO:0140297; GO:2000001; GO:2000323; GO:2000850"
"FUN_007022","ME9","ptg000001l:19386902-19398415","Q8WP19","Cryptochrome-1","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","circadian regulation of gene expression [GO:0032922]; circadian rhythm [GO:0007623]; entrainment of circadian clock by photoperiod [GO:0043153]; gluconeogenesis [GO:0006094]; glucose homeostasis [GO:0042593]; negative regulation of circadian rhythm [GO:0042754]; negative regulation of DNA-templated transcription [GO:0045892]; negative regulation of G protein-coupled receptor signaling pathway [GO:0045744]; negative regulation of glucocorticoid receptor signaling pathway [GO:2000323]; negative regulation of gluconeogenesis [GO:0045721]; negative regulation of protein ubiquitination [GO:0031397]; negative regulation of transcription by RNA polymerase II [GO:0000122]; positive regulation of protein ubiquitination [GO:0031398]; regulation of circadian rhythm [GO:0042752]; regulation of DNA damage checkpoint [GO:2000001]; response to activity [GO:0014823]; response to glucagon [GO:0033762]; response to light stimulus [GO:0009416]; signal transduction in response to DNA damage [GO:0042770]","GO:0000122; GO:0000166; GO:0005634; GO:0005737; GO:0006094; GO:0007623; GO:0009416; GO:0009881; GO:0014823; GO:0031397; GO:0031398; GO:0032922; GO:0033762; GO:0042593; GO:0042752; GO:0042754; GO:0042770; GO:0043153; GO:0045721; GO:0045744; GO:0045892; GO:2000001; GO:2000323"
"FUN_008036","ME6","ptg000002l:7412717-7415329","Q9Z186","Glucose-6-phosphatase 2 (G-6-Pase 2) (G6Pase 2) (EC 3.1.3.9) (Islet-specific glucose-6-phosphatase catalytic subunit-related protein)","Mus musculus (Mouse)","gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; regulation of insulin secretion [GO:0050796]","GO:0005783; GO:0005789; GO:0006094; GO:0016020; GO:0016787; GO:0042593; GO:0050796; GO:0051156"
"FUN_008237","ME13","ptg000002l:9549733-9562655","Q29RK2","Pyruvate carboxylase, mitochondrial (EC 6.4.1.1) (Pyruvic carboxylase) (PCB)","Bos taurus (Bovine)","gluconeogenesis [GO:0006094]; lipid metabolic process [GO:0006629]; NADH metabolic process [GO:0006734]; NADP metabolic process [GO:0006739]; negative regulation of gene expression [GO:0010629]; positive regulation by host of viral process [GO:0044794]; pyruvate metabolic process [GO:0006090]; viral release from host cell [GO:0019076]; viral RNA genome packaging [GO:0019074]","GO:0004736; GO:0005524; GO:0005737; GO:0005739; GO:0005743; GO:0005759; GO:0006090; GO:0006094; GO:0006629; GO:0006734; GO:0006739; GO:0010629; GO:0019074; GO:0019076; GO:0042802; GO:0044794; GO:0046872"
"FUN_008282","ME3","ptg000002l:9911971-9929166","Q9VCU9","Endoribonuclease Dcr-1 (Protein dicer-1) (EC 3.1.26.-)","Drosophila melanogaster (Fruit fly)","apoptotic DNA fragmentation [GO:0006309]; dendrite morphogenesis [GO:0048813]; dsRNA transport [GO:0033227]; germ-line stem cell division [GO:0042078]; germarium-derived female germ-line cyst formation [GO:0030727]; germarium-derived oocyte fate determination [GO:0007294]; miRNA processing [GO:0035196]; mitotic cell cycle, embryonic [GO:0045448]; pole cell formation [GO:0007279]; pre-miRNA processing [GO:0031054]; response to starvation [GO:0042594]; RISC complex assembly [GO:0070922]; RNA phosphodiester bond hydrolysis [GO:0090501]; RNA-mediated post-transcriptional gene silencing [GO:0035194]; segment polarity determination [GO:0007367]; siRNA processing [GO:0030422]","GO:0003723; GO:0003727; GO:0004386; GO:0004525; GO:0004530; GO:0005524; GO:0005737; GO:0006309; GO:0007279; GO:0007294; GO:0007367; GO:0016442; GO:0016443; GO:0030422; GO:0030727; GO:0031054; GO:0033227; GO:0035194; GO:0035196; GO:0042078; GO:0042594; GO:0045448; GO:0046872; GO:0048813; GO:0070578; GO:0070883; GO:0070922; GO:0090501"
"FUN_008296","ME1","ptg000002l:10054447-10061170","Q9DBY1","E3 ubiquitin-protein ligase synoviolin (EC 2.3.2.27) (RING-type E3 ubiquitin transferase synoviolin) (Synovial apoptosis inhibitor 1)","Mus musculus (Mouse)","ERAD pathway [GO:0036503]; immature B cell differentiation [GO:0002327]; in utero embryonic development [GO:0001701]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway [GO:1902236]; protein catabolic process [GO:0030163]; protein K48-linked ubiquitination [GO:0070936]; protein stabilization [GO:0050821]; protein ubiquitination [GO:0016567]; response to unfolded protein [GO:0006986]; retrograde protein transport, ER to cytosol [GO:0030970]; ubiquitin-dependent ERAD pathway [GO:0030433]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0000151; GO:0000839; GO:0001701; GO:0002327; GO:0005654; GO:0005783; GO:0005790; GO:0006511; GO:0006986; GO:0016567; GO:0030163; GO:0030433; GO:0030970; GO:0036503; GO:0036513; GO:0044322; GO:0046872; GO:0050821; GO:0051082; GO:0051087; GO:0051117; GO:0061630; GO:0070059; GO:0070936; GO:1902236; GO:1990381"
"FUN_008588","ME3","ptg000002l:13126776-13192147","Q5U3U3","Carnitine O-palmitoyltransferase 2, mitochondrial (EC 2.3.1.21) (Carnitine palmitoyltransferase II) (CPT II)","Danio rerio (Zebrafish) (Brachydanio rerio)","fatty acid beta-oxidation [GO:0006635]","GO:0004095; GO:0005739; GO:0005743; GO:0006635; GO:0008458"
"FUN_008617","ME33","ptg000002l:13675438-13682105","Q5XTS1","Calcium-independent phospholipase A2-gamma (EC 3.1.1.-) (EC 3.1.1.5) (Group VIB calcium-independent phospholipase A2) (Intracellular membrane-associated calcium-independent phospholipase A2 gamma) (iPLA2-gamma) (Patatin-like phospholipase domain-containing protein 8)","Oryctolagus cuniculus (Rabbit)","arachidonic acid metabolic process [GO:0019369]; cardiolipin metabolic process [GO:0032048]; lipid catabolic process [GO:0016042]; lipid homeostasis [GO:0055088]; triglyceride homeostasis [GO:0070328]","GO:0004622; GO:0005739; GO:0005777; GO:0005778; GO:0005789; GO:0008970; GO:0016020; GO:0016042; GO:0019369; GO:0031966; GO:0032048; GO:0047499; GO:0055088; GO:0070328; GO:0102545"
"FUN_008660","ME14","ptg000002l:14136576-14138681","Q5R9Y4","Ras-related protein Rab-7a (EC 3.6.5.2)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","early endosome to late endosome transport [GO:0045022]; endosome to plasma membrane protein transport [GO:0099638]; lipid catabolic process [GO:0016042]; lipophagy [GO:0061724]; phagosome acidification [GO:0090383]; phagosome-lysosome fusion [GO:0090385]","GO:0000421; GO:0003925; GO:0005525; GO:0005739; GO:0005765; GO:0005770; GO:0005811; GO:0005829; GO:0016042; GO:0030670; GO:0031902; GO:0031966; GO:0033162; GO:0045022; GO:0045335; GO:0061724; GO:0090383; GO:0090385; GO:0099638"
"FUN_008934","ME8","ptg000004l:622874-629747","A5D7I4","Exostosin-1 (EC 2.4.1.224) (EC 2.4.1.225) (Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase) (Multiple exostoses protein 1 homolog)","Bos taurus (Bovine)","antigen processing and presentation [GO:0019882]; axon guidance [GO:0007411]; basement membrane organization [GO:0071711]; blood vessel remodeling [GO:0001974]; BMP signaling pathway [GO:0030509]; bone resorption [GO:0045453]; canonical Wnt signaling pathway [GO:0060070]; cartilage development involved in endochondral bone morphogenesis [GO:0060351]; cell adhesion mediated by integrin [GO:0033627]; cell fate commitment [GO:0045165]; cellular response to virus [GO:0098586]; chondrocyte hypertrophy [GO:0003415]; chondrocyte proliferation [GO:0035988]; chondroitin sulfate metabolic process [GO:0030204]; collagen fibril organization [GO:0030199]; cranial skeletal system development [GO:1904888]; dendrite self-avoidance [GO:0070593]; dendritic cell migration [GO:0036336]; developmental growth involved in morphogenesis [GO:0060560]; embryonic skeletal joint development [GO:0072498]; endochondral bone growth [GO:0003416]; endochondral ossification [GO:0001958]; endoderm development [GO:0007492]; epithelial tube branching involved in lung morphogenesis [GO:0060441]; fear response [GO:0042596]; fibroblast growth factor receptor signaling pathway [GO:0008543]; fluid transport [GO:0042044]; gastrulation [GO:0007369]; gene expression [GO:0010467]; glandular epithelial cell differentiation [GO:0002067]; glomerular basement membrane development [GO:0032836]; hair follicle morphogenesis [GO:0031069]; heart contraction [GO:0060047]; heart field specification [GO:0003128]; hematopoietic stem cell differentiation [GO:0060218]; hematopoietic stem cell homeostasis [GO:0061484]; hematopoietic stem cell migration to bone marrow [GO:0097241]; heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process [GO:0015014]; heparin biosynthetic process [GO:0030210]; hypersensitivity [GO:0002524]; leukocyte tethering or rolling [GO:0050901]; limb joint morphogenesis [GO:0036022]; lymphocyte adhesion to endothelial cell of high endothelial venule [GO:0036339]; lymphocyte migration into lymphoid organs [GO:0097021]; mesenchymal cell differentiation involved in bone development [GO:1901706]; mesoderm development [GO:0007498]; motor behavior [GO:0061744]; multicellular organism growth [GO:0035264]; multicellular organismal water homeostasis [GO:0050891]; neural crest cell differentiation [GO:0014033]; olfactory bulb development [GO:0021772]; optic nerve development [GO:0021554]; ossification involved in bone maturation [GO:0043931]; perichondral bone morphogenesis [GO:0061974]; podocyte differentiation [GO:0072112]; protein catabolic process [GO:0030163]; protein glycosylation [GO:0006486]; protein-containing complex assembly [GO:0065003]; regulation of blood pressure [GO:0008217]; response to heparin [GO:0071503]; response to leukemia inhibitory factor [GO:1990823]; response to light intensity [GO:0009642]; sebaceous gland development [GO:0048733]; smoothened signaling pathway involved in lung development [GO:0060506]; social behavior [GO:0035176]; sodium ion homeostasis [GO:0055078]; stem cell division [GO:0017145]; stomach development [GO:0062094]; sulfation [GO:0051923]; sweat gland development [GO:0060792]; synaptic transmission, glutamatergic [GO:0035249]; tight junction organization [GO:0120193]; TNFSF11-mediated signaling pathway [GO:0071847]; vacuole organization [GO:0007033]; vasodilation [GO:0042311]; vocalization behavior [GO:0071625]; wound healing [GO:0042060]","GO:0000139; GO:0001958; GO:0001974; GO:0002067; GO:0002524; GO:0003128; GO:0003415; GO:0003416; GO:0005789; GO:0005794; GO:0006486; GO:0007033; GO:0007369; GO:0007411; GO:0007492; GO:0007498; GO:0008217; GO:0008375; GO:0008543; GO:0009642; GO:0010467; GO:0014033; GO:0015014; GO:0015020; GO:0016757; GO:0017145; GO:0019882; GO:0021554; GO:0021772; GO:0030163; GO:0030199; GO:0030204; GO:0030210; GO:0030509; GO:0031069; GO:0032836; GO:0033627; GO:0035176; GO:0035249; GO:0035264; GO:0035988; GO:0036022; GO:0036336; GO:0036339; GO:0042044; GO:0042060; GO:0042311; GO:0042596; GO:0042803; GO:0043931; GO:0045165; GO:0045202; GO:0045453; GO:0046872; GO:0046982; GO:0048733; GO:0050508; GO:0050509; GO:0050891; GO:0050901; GO:0051923; GO:0055078; GO:0060047; GO:0060070; GO:0060218; GO:0060351; GO:0060441; GO:0060506; GO:0060560; GO:0060792; GO:0061484; GO:0061744; GO:0061974; GO:0062094; GO:0065003; GO:0070593; GO:0071503; GO:0071625; GO:0071711; GO:0071847; GO:0072112; GO:0072498; GO:0097021; GO:0097241; GO:0098586; GO:0120193; GO:1901706; GO:1904888; GO:1990823"
"FUN_009532","ME0","ptg000004l:8124143-8148796","D3ZQD3","2-oxoglutarate dehydrogenase-like, mitochondrial (EC 1.2.4.2) (2-oxoglutarate dehydrogenase complex component E1-like) (OGDC-E1-like) (Alpha-ketoglutarate dehydrogenase-like)","Rattus norvegicus (Rat)","2-oxoglutarate metabolic process [GO:0006103]; glycolytic process [GO:0006096]; tricarboxylic acid cycle [GO:0006099]","GO:0004591; GO:0005739; GO:0005759; GO:0006096; GO:0006099; GO:0006103; GO:0030976; GO:0045252; GO:0046872"
"FUN_010664","ME2","ptg000007l:1335315-1347675","O46629","Trifunctional enzyme subunit beta, mitochondrial (TP-beta) [Includes: 3-ketoacyl-CoA thiolase (EC 2.3.1.155) (EC 2.3.1.16) (Acetyl-CoA acyltransferase) (Beta-ketothiolase)]","Bos taurus (Bovine)","fatty acid beta-oxidation [GO:0006635]","GO:0003988; GO:0005739; GO:0005741; GO:0005743; GO:0005783; GO:0006635; GO:0050633"
"FUN_010919","ME9","ptg000007l:4213722-4252397","B2RQC6","CAD protein [Includes: Glutamine-dependent carbamoyl-phosphate synthase (EC 6.3.5.5); Aspartate carbamoyltransferase (EC 2.1.3.2); Dihydroorotase (EC 3.5.2.3)]","Mus musculus (Mouse)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; 'de novo' UMP biosynthetic process [GO:0044205]; citrulline biosynthetic process [GO:0019240]; glutamine metabolic process [GO:0006541]; nitrogen compound metabolic process [GO:0006807]; peptidyl-threonine phosphorylation [GO:0018107]; protein autophosphorylation [GO:0046777]; response to insulin [GO:0032868]; response to starvation [GO:0042594]; UDP biosynthetic process [GO:0006225]; UTP biosynthetic process [GO:0006228]; xenobiotic metabolic process [GO:0006805]","GO:0002134; GO:0004070; GO:0004088; GO:0004151; GO:0004672; GO:0005524; GO:0005634; GO:0005737; GO:0005829; GO:0006207; GO:0006225; GO:0006228; GO:0006541; GO:0006805; GO:0006807; GO:0008270; GO:0016363; GO:0016597; GO:0018107; GO:0019240; GO:0019899; GO:0032868; GO:0032991; GO:0036094; GO:0042594; GO:0042802; GO:0042995; GO:0043025; GO:0043195; GO:0044205; GO:0046777"
"FUN_011908","ME14","ptg000008l:2748000-2770398","Q5R4G2","Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283]","GO:0001650; GO:0003847; GO:0005829; GO:0005886; GO:0007283; GO:0008247; GO:0016042; GO:0016239; GO:0042803; GO:0046982"
"FUN_011931","ME3","ptg000008l:3236245-3243922","Q9BWD1","Acetyl-CoA acetyltransferase, cytosolic (EC 2.3.1.9) (Acetyl-CoA transferase-like protein) (Cytosolic acetoacetyl-CoA thiolase)","Homo sapiens (Human)","fatty acid beta-oxidation [GO:0006635]; lipid metabolic process [GO:0006629]","GO:0003985; GO:0005737; GO:0005739; GO:0005829; GO:0006629; GO:0006635; GO:0070062"
"FUN_012329","ME42","ptg000008l:7926529-7930091","Q6GMR7","Fatty-acid amide hydrolase 2 (EC 3.5.1.99) (Amidase domain-containing protein) (Anandamide amidohydrolase 2) (Oleamide hydrolase 2)","Homo sapiens (Human)","arachidonic acid metabolic process [GO:0019369]; lipid catabolic process [GO:0016042]","GO:0005811; GO:0016020; GO:0016042; GO:0017064; GO:0019369"
"FUN_012468","ME16","ptg000008l:9188457-9189708","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_012469","ME17","ptg000008l:9204606-9205869","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_012470","ME35","ptg000008l:9209811-9214981","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_012471","ME7","ptg000008l:9215306-9216413","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_012473","ME47","ptg000008l:9225671-9226793","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_012474","ME1","ptg000008l:9228493-9235608","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_014993","ME12","ptg000009l:5080958-5084633","P51659","Peroxisomal multifunctional enzyme type 2 (MFE-2) (17-beta-hydroxysteroid dehydrogenase 4) (17-beta-HSD 4) (D-bifunctional protein) (DBP) (Multifunctional protein 2) (MFP-2) (Short chain dehydrogenase/reductase family 8C member 1) [Cleaved into: (3R)-hydroxyacyl-CoA dehydrogenase (EC 1.1.1.n12); Enoyl-CoA hydratase 2 (EC 4.2.1.107) (EC 4.2.1.119) (3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholest-24-enoyl-CoA hydratase)]","Homo sapiens (Human)","androgen metabolic process [GO:0008209]; estrogen metabolic process [GO:0008210]; fatty acid beta-oxidation [GO:0006635]; medium-chain fatty-acyl-CoA metabolic process [GO:0036112]; osteoblast differentiation [GO:0001649]; Sertoli cell development [GO:0060009]; very long-chain fatty acid metabolic process [GO:0000038]; very long-chain fatty-acyl-CoA metabolic process [GO:0036111]","GO:0000038; GO:0001649; GO:0003857; GO:0004300; GO:0005777; GO:0005778; GO:0005782; GO:0005829; GO:0006635; GO:0008209; GO:0008210; GO:0016020; GO:0016508; GO:0016853; GO:0033989; GO:0036111; GO:0036112; GO:0042803; GO:0044594; GO:0060009; GO:0106386"
"FUN_015323","ME3","ptg000009l:8836715-8843555","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_015352","ME1","ptg000009l:9116551-9124784","Q4R4S5","Lysosomal acid lipase/cholesteryl ester hydrolase (Acid cholesteryl ester hydrolase) (LAL) (EC 3.1.1.13) (Cholesteryl esterase) (Lipase A) (Sterol esterase)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","lipid catabolic process [GO:0016042]","GO:0004771; GO:0005764; GO:0016042"
"FUN_015356","ME1","ptg000009l:9161634-9168045","Q8K2A6","Lipase member M (EC 3.1.1.-) (Lipase-like abhydrolase domain-containing protein 3)","Mus musculus (Mouse)","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016788"
"FUN_015434","ME14","ptg000009l:10125666-10128350","P53448","Fructose-bisphosphate aldolase C (EC 4.1.2.13) (Brain-type aldolase)","Carassius auratus (Goldfish)","fructose 1,6-bisphosphate metabolic process [GO:0030388]; glycolytic process [GO:0006096]","GO:0004332; GO:0006096; GO:0030388"
"FUN_017849","ME9","ptg000012l:1096632-1104039","O35910","Monocarboxylate transporter 4 (MCT 4) (Monocarboxylate transporter 3) (MCT 3) (Solute carrier family 16 member 3)","Rattus norvegicus (Rat)","lactate transmembrane transport [GO:0035873]; monocarboxylic acid transport [GO:0015718]; plasma membrane lactate transport [GO:0035879]; protein catabolic process [GO:0030163]; pyruvate catabolic process [GO:0042867]; pyruvate transmembrane transport [GO:1901475]","GO:0005886; GO:0008028; GO:0015129; GO:0015650; GO:0015718; GO:0016020; GO:0016323; GO:0016324; GO:0016328; GO:0030163; GO:0031965; GO:0035873; GO:0035879; GO:0042867; GO:0045202; GO:0050833; GO:0098688; GO:0098839; GO:1901475"
"FUN_018008","ME13","ptg000012l:3079482-3120350","P07756","Carbamoyl-phosphate synthase [ammonia], mitochondrial (EC 6.3.4.16) (Carbamoyl-phosphate synthetase I) (CPSase I)","Rattus norvegicus (Rat)","'de novo' pyrimidine nucleobase biosynthetic process [GO:0006207]; anion homeostasis [GO:0055081]; carbamoyl phosphate biosynthetic process [GO:0070409]; cellular response to ammonium ion [GO:0071242]; cellular response to cAMP [GO:0071320]; cellular response to fibroblast growth factor stimulus [GO:0044344]; cellular response to glucagon stimulus [GO:0071377]; cellular response to oleic acid [GO:0071400]; glutamine metabolic process [GO:0006541]; hepatocyte differentiation [GO:0070365]; homocysteine metabolic process [GO:0050667]; liver development [GO:0001889]; midgut development [GO:0007494]; nitric oxide metabolic process [GO:0046209]; nitrogen compound metabolic process [GO:0006807]; response to amine [GO:0014075]; response to amino acid [GO:0043200]; response to cAMP [GO:0051591]; response to dexamethasone [GO:0071548]; response to food [GO:0032094]; response to glucagon [GO:0033762]; response to glucocorticoid [GO:0051384]; response to growth hormone [GO:0060416]; response to lipopolysaccharide [GO:0032496]; response to oleic acid [GO:0034201]; response to starvation [GO:0042594]; response to steroid hormone [GO:0048545]; response to toxic substance [GO:0009636]; response to xenobiotic stimulus [GO:0009410]; response to zinc ion [GO:0010043]; sequestering of metal ion [GO:0051238]; triglyceride catabolic process [GO:0019433]; urea cycle [GO:0000050]; vasodilation [GO:0042311]","GO:0000050; GO:0001889; GO:0004087; GO:0004088; GO:0004175; GO:0005509; GO:0005524; GO:0005543; GO:0005730; GO:0005737; GO:0005739; GO:0005743; GO:0006207; GO:0006541; GO:0006807; GO:0007494; GO:0009410; GO:0009636; GO:0010043; GO:0014075; GO:0016595; GO:0019433; GO:0032094; GO:0032496; GO:0032991; GO:0033762; GO:0034201; GO:0036094; GO:0042311; GO:0042594; GO:0042645; GO:0043200; GO:0044344; GO:0044877; GO:0046209; GO:0046872; GO:0048545; GO:0050667; GO:0051238; GO:0051384; GO:0051591; GO:0055081; GO:0060416; GO:0070365; GO:0070409; GO:0071242; GO:0071320; GO:0071377; GO:0071400; GO:0071548; GO:0072341"
"FUN_022926","ME17","ptg000017l:1633881-1634995","F1RBC8","ATP-binding cassette sub-family D member 1 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy protein) (ALDP)","Danio rerio (Zebrafish) (Brachydanio rerio)","adrenal gland development [GO:0030325]; cholesterol transport [GO:0030301]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; motor behavior [GO:0061744]; oligodendrocyte development [GO:0014003]; peroxisome organization [GO:0007031]; positive regulation of myelination [GO:0031643]; swimming behavior [GO:0036269]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0006635; GO:0007031; GO:0014003; GO:0015607; GO:0015910; GO:0016887; GO:0030301; GO:0030325; GO:0031643; GO:0036269; GO:0042626; GO:0042760; GO:0047617; GO:0061744"
"FUN_022927","ME17","ptg000017l:1639371-1640938","F1RBC8","ATP-binding cassette sub-family D member 1 (EC 3.1.2.-) (EC 7.6.2.-) (Adrenoleukodystrophy protein) (ALDP)","Danio rerio (Zebrafish) (Brachydanio rerio)","adrenal gland development [GO:0030325]; cholesterol transport [GO:0030301]; fatty acid beta-oxidation [GO:0006635]; long-chain fatty acid import into peroxisome [GO:0015910]; motor behavior [GO:0061744]; oligodendrocyte development [GO:0014003]; peroxisome organization [GO:0007031]; positive regulation of myelination [GO:0031643]; swimming behavior [GO:0036269]; very long-chain fatty acid catabolic process [GO:0042760]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0005324; GO:0005524; GO:0005777; GO:0005778; GO:0006635; GO:0007031; GO:0014003; GO:0015607; GO:0015910; GO:0016887; GO:0030301; GO:0030325; GO:0031643; GO:0036269; GO:0042626; GO:0042760; GO:0047617; GO:0061744"
"FUN_023361","ME8","ptg000017l:6671734-6676309","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_023367","ME1","ptg000017l:6723553-6730063","P17712","Hexokinase-4 (HK4) (EC 2.7.1.1) (Glucokinase) (Hexokinase type IV) (HK IV) (Hexokinase-D)","Rattus norvegicus (Rat)","calcium ion import [GO:0070509]; carbohydrate phosphorylation [GO:0046835]; cellular glucose homeostasis [GO:0001678]; cellular response to glucose starvation [GO:0042149]; cellular response to insulin stimulus [GO:0032869]; cellular response to leptin stimulus [GO:0044320]; detection of glucose [GO:0051594]; fructose 2,6-bisphosphate metabolic process [GO:0006003]; fructose 6-phosphate metabolic process [GO:0006002]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glucose metabolic process [GO:0006006]; glycogen biosynthetic process [GO:0005978]; glycolytic process [GO:0006096]; lipid homeostasis [GO:0055088]; mannose metabolic process [GO:0006013]; NADP metabolic process [GO:0006739]; negative regulation of epinephrine secretion [GO:0032811]; negative regulation of gluconeogenesis [GO:0045721]; positive regulation of cytosolic calcium ion concentration [GO:0007204]; positive regulation of glycogen biosynthetic process [GO:0045725]; positive regulation of glycolytic process [GO:0045821]; positive regulation of insulin secretion [GO:0032024]; positive regulation of phosphorylation [GO:0042327]; regulation of insulin secretion [GO:0050796]; regulation of potassium ion transport [GO:0043266]; response to glucose [GO:0009749]; second-messenger-mediated signaling [GO:0019932]","GO:0000287; GO:0001678; GO:0004340; GO:0004396; GO:0005524; GO:0005536; GO:0005634; GO:0005654; GO:0005737; GO:0005739; GO:0005829; GO:0005938; GO:0005978; GO:0006002; GO:0006003; GO:0006006; GO:0006013; GO:0006096; GO:0006739; GO:0007204; GO:0008865; GO:0009749; GO:0019158; GO:0019903; GO:0019932; GO:0030141; GO:0032024; GO:0032811; GO:0032869; GO:0042149; GO:0042327; GO:0042593; GO:0043266; GO:0043531; GO:0044320; GO:0045180; GO:0045721; GO:0045725; GO:0045821; GO:0046835; GO:0050796; GO:0051156; GO:0051594; GO:0055088; GO:0070509"
"FUN_023403","ME0","ptg000017l:7171736-7192592","Q9CR35","Chymotrypsinogen B (EC 3.4.21.1) [Cleaved into: Chymotrypsin B chain A; Chymotrypsin B chain B; Chymotrypsin B chain C]","Mus musculus (Mouse)","digestion [GO:0007586]; positive regulation of apoptotic process [GO:0043065]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to cytokine [GO:0034097]","GO:0004252; GO:0005615; GO:0005737; GO:0005764; GO:0006508; GO:0007586; GO:0008233; GO:0008236; GO:0030163; GO:0034097; GO:0043065"
"FUN_023596","ME2","ptg000017l:9699993-9702655","Q9Y5Y6","Suppressor of tumorigenicity 14 protein (EC 3.4.21.109) (Matriptase) (Membrane-type serine protease 1) (MT-SP1) (Prostamin) (Serine protease 14) (Serine protease TADG-15) (Tumor-associated differentially-expressed gene 15 protein)","Homo sapiens (Human)","epithelial cell morphogenesis involved in placental branching [GO:0060672]; keratinocyte differentiation [GO:0030216]; neural tube closure [GO:0001843]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0001843; GO:0004252; GO:0005615; GO:0005886; GO:0006508; GO:0008236; GO:0009897; GO:0016323; GO:0030163; GO:0030216; GO:0060672"
"FUN_023676","ME6","ptg000017l:10545638-10548340","Q02083","N-acylethanolamine-hydrolyzing acid amidase (EC 3.5.1.60) (Acid ceramidase-like protein) (Acylsphingosine deacylase NAAA) (EC 3.5.1.23) (N-acylsphingosine amidohydrolase-like) (ASAH-like protein) [Cleaved into: N-acylethanolamine-hydrolyzing acid amidase subunit alpha; N-acylethanolamine-hydrolyzing acid amidase subunit beta]","Homo sapiens (Human)","fatty acid metabolic process [GO:0006631]; lipid catabolic process [GO:0016042]; N-acylethanolamine metabolic process [GO:0070291]; N-acylphosphatidylethanolamine metabolic process [GO:0070292]; sphingosine metabolic process [GO:0006670]","GO:0005737; GO:0005764; GO:0006631; GO:0006670; GO:0016042; GO:0016810; GO:0017040; GO:0017064; GO:0019898; GO:0043202; GO:0047412; GO:0070062; GO:0070291; GO:0070292; GO:0102121; GO:0140297"
"FUN_025232","ME2","ptg000019l:257406-264111","P55070","Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","Lactarius deterrimus (False saffron milkcap)","glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006096; GO:0051287"
"FUN_025392","ME6","ptg000019l:2187635-2190134","P97864","Caspase-7 (CASP-7) (EC 3.4.22.60) (Apoptotic protease Mch-3) (Cysteine protease LICE2) [Cleaved into: Caspase-7 subunit p20; Caspase-7 subunit p11]","Mus musculus (Mouse)","apoptotic process [GO:0006915]; cellular response to staurosporine [GO:0072734]; defense response to bacterium [GO:0042742]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast apoptotic process [GO:0044346]; heart development [GO:0007507]; inflammatory response [GO:0006954]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; lymphocyte apoptotic process [GO:0070227]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of plasma membrane repair [GO:1905686]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; response to UV [GO:0009411]","GO:0003723; GO:0004190; GO:0004197; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006954; GO:0007507; GO:0008233; GO:0008234; GO:0008303; GO:0009411; GO:0016485; GO:0030163; GO:0035556; GO:0042742; GO:0043065; GO:0043231; GO:0044346; GO:0051402; GO:0070227; GO:0072734; GO:0097153; GO:0097191; GO:0097193; GO:0097194; GO:0097200; GO:1905686"
"FUN_025670","ME1","ptg000019l:5463897-5476305","P50542","Peroxisomal targeting signal 1 receptor (PTS1 receptor) (PTS1R) (PTS1-BP) (Peroxin-5) (Peroxisomal C-terminal targeting signal import receptor) (Peroxisome receptor 1)","Homo sapiens (Human)","cell development [GO:0048468]; cerebral cortex cell migration [GO:0021795]; cerebral cortex neuron differentiation [GO:0021895]; endoplasmic reticulum organization [GO:0007029]; fatty acid beta-oxidation [GO:0006635]; mitochondrial membrane organization [GO:0007006]; negative regulation of protein-containing complex assembly [GO:0031333]; neuromuscular process [GO:0050905]; neuron migration [GO:0001764]; pexophagy [GO:0000425]; positive regulation of multicellular organism growth [GO:0040018]; protein import into peroxisome matrix [GO:0016558]; protein import into peroxisome matrix, docking [GO:0016560]; protein import into peroxisome matrix, receptor recycling [GO:0016562]; protein import into peroxisome matrix, substrate release [GO:0044721]; protein import into peroxisome matrix, translocation [GO:0016561]; protein import into peroxisome membrane [GO:0045046]; protein targeting to peroxisome [GO:0006625]; protein tetramerization [GO:0051262]; very long-chain fatty acid metabolic process [GO:0000038]","GO:0000038; GO:0000268; GO:0000425; GO:0001764; GO:0005052; GO:0005737; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0005794; GO:0005829; GO:0006625; GO:0006635; GO:0007006; GO:0007029; GO:0008022; GO:0016020; GO:0016558; GO:0016560; GO:0016561; GO:0016562; GO:0019899; GO:0021795; GO:0021895; GO:0031267; GO:0031333; GO:0032991; GO:0033328; GO:0040018; GO:0044183; GO:0044721; GO:0045046; GO:0047485; GO:0048468; GO:0050905; GO:0051262; GO:0140597"
"FUN_025823","ME13","ptg000020l:1001303-1026455","P53396","ATP-citrate synthase (EC 2.3.3.8) (ATP-citrate (pro-S-)-lyase) (ACL) (Citrate cleavage enzyme)","Homo sapiens (Human)","acetyl-CoA biosynthetic process [GO:0006085]; cholesterol biosynthetic process [GO:0006695]; citrate metabolic process [GO:0006101]; coenzyme A metabolic process [GO:0015936]; fatty acid biosynthetic process [GO:0006633]; lipid biosynthetic process [GO:0008610]; oxaloacetate metabolic process [GO:0006107]; tricarboxylic acid cycle [GO:0006099]","GO:0003878; GO:0005524; GO:0005576; GO:0005654; GO:0005829; GO:0006085; GO:0006099; GO:0006101; GO:0006107; GO:0006633; GO:0006695; GO:0008610; GO:0015936; GO:0016020; GO:0035578; GO:0046872; GO:0070062; GO:1904813"
"FUN_026128","ME41","ptg000020l:4918603-4924154","P42574","Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]","Homo sapiens (Human)","anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; apoptotic signaling pathway [GO:0097190]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to staurosporine [GO:0072734]; epithelial cell apoptotic process [GO:1904019]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of B cell proliferation [GO:0030889]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; platelet formation [GO:0030220]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of macroautophagy [GO:0016241]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to tumor necrosis factor [GO:0034612]; response to UV [GO:0009411]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]","GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005654; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008303; GO:0008627; GO:0009410; GO:0009411; GO:0009749; GO:0010165; GO:0016005; GO:0016241; GO:0016485; GO:0021766; GO:0030163; GO:0030182; GO:0030216; GO:0030218; GO:0030220; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0034612; GO:0035094; GO:0042060; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043200; GO:0043525; GO:0044346; GO:0044877; GO:0045121; GO:0045165; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0071887; GO:0072734; GO:0097153; GO:0097190; GO:0097191; GO:0097193; GO:0097194; GO:0097199; GO:0097200; GO:1902004; GO:1902512; GO:1904019"
"FUN_027948","ME32","ptg000021l:13714157-13715126","Q63HM9","PI-PLC X domain-containing protein 3","Homo sapiens (Human)","lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]","GO:0005737; GO:0007165; GO:0008081; GO:0016042; GO:0045202"
"FUN_027950","ME0","ptg000021l:13725066-13726137","Q58EK3","PI-PLC X domain-containing protein 3","Danio rerio (Zebrafish) (Brachydanio rerio)","lipid catabolic process [GO:0016042]; signal transduction [GO:0007165]","GO:0007165; GO:0008081; GO:0016042; GO:0045202"
"FUN_028200","ME2","ptg000021l:16810807-16815447","Q4R7L3","26S proteasome regulatory subunit 6B (26S proteasome AAA-ATPase subunit RPT3) (Proteasome 26S subunit ATPase 4)","Macaca fascicularis (Crab-eating macaque) (Cynomolgus monkey)","protein catabolic process [GO:0030163]","GO:0005524; GO:0005654; GO:0005829; GO:0016887; GO:0022624; GO:0030163; GO:0036402"
"FUN_029188","ME0","ptg000022l:9130844-9134575","P70677","Caspase-3 (CASP-3) (EC 3.4.22.56) (Apopain) (Cysteine protease CPP32) (CPP-32) (LICE) (Protein Yama) (SREBP cleavage activity 1) (SCA-1) [Cleaved into: Caspase-3 subunit p17; Caspase-3 subunit p12]","Mus musculus (Mouse)","anterior neural tube closure [GO:0061713]; apoptotic process [GO:0006915]; axonal fasciculation [GO:0007413]; B cell homeostasis [GO:0001782]; cell fate commitment [GO:0045165]; cellular response to DNA damage stimulus [GO:0006974]; cellular response to organic substance [GO:0071310]; cellular response to staurosporine [GO:0072734]; epithelial cell apoptotic process [GO:1904019]; erythrocyte differentiation [GO:0030218]; execution phase of apoptosis [GO:0097194]; extrinsic apoptotic signaling pathway [GO:0097191]; fibroblast apoptotic process [GO:0044346]; glial cell apoptotic process [GO:0034349]; heart development [GO:0007507]; hippocampus development [GO:0021766]; intracellular signal transduction [GO:0035556]; intrinsic apoptotic signaling pathway [GO:0097193]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; intrinsic apoptotic signaling pathway in response to osmotic stress [GO:0008627]; keratinocyte differentiation [GO:0030216]; learning or memory [GO:0007611]; leukocyte apoptotic process [GO:0071887]; luteolysis [GO:0001554]; negative regulation of activated T cell proliferation [GO:0046007]; negative regulation of apoptotic process [GO:0043066]; negative regulation of B cell proliferation [GO:0030889]; negative regulation of cell cycle [GO:0045786]; negative regulation of cyclin-dependent protein serine/threonine kinase activity [GO:0045736]; neuron apoptotic process [GO:0051402]; neuron differentiation [GO:0030182]; neurotrophin TRK receptor signaling pathway [GO:0048011]; positive regulation of amyloid-beta formation [GO:1902004]; positive regulation of apoptotic DNA fragmentation [GO:1902512]; positive regulation of apoptotic process [GO:0043065]; positive regulation of neuron apoptotic process [GO:0043525]; protein catabolic process [GO:0030163]; protein processing [GO:0016485]; proteolysis [GO:0006508]; regulation of protein stability [GO:0031647]; response to amino acid [GO:0043200]; response to antibiotic [GO:0046677]; response to cobalt ion [GO:0032025]; response to estradiol [GO:0032355]; response to glucocorticoid [GO:0051384]; response to glucose [GO:0009749]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to lipopolysaccharide [GO:0032496]; response to nicotine [GO:0035094]; response to organic substance [GO:0010033]; response to UV [GO:0009411]; response to wounding [GO:0009611]; response to X-ray [GO:0010165]; response to xenobiotic stimulus [GO:0009410]; sensory perception of sound [GO:0007605]; striated muscle cell differentiation [GO:0051146]; T cell homeostasis [GO:0043029]; wound healing [GO:0042060]","GO:0001554; GO:0001666; GO:0001782; GO:0002020; GO:0004175; GO:0004190; GO:0004197; GO:0004861; GO:0005123; GO:0005634; GO:0005737; GO:0005829; GO:0006508; GO:0006915; GO:0006974; GO:0007413; GO:0007507; GO:0007605; GO:0007611; GO:0008233; GO:0008234; GO:0008303; GO:0008627; GO:0009410; GO:0009411; GO:0009611; GO:0009749; GO:0010033; GO:0010165; GO:0016005; GO:0016485; GO:0021766; GO:0030163; GO:0030182; GO:0030216; GO:0030218; GO:0030889; GO:0031264; GO:0031647; GO:0032025; GO:0032355; GO:0032496; GO:0034349; GO:0035094; GO:0035556; GO:0042060; GO:0042542; GO:0043025; GO:0043029; GO:0043065; GO:0043066; GO:0043200; GO:0043525; GO:0044346; GO:0044877; GO:0045121; GO:0045165; GO:0045736; GO:0045786; GO:0046007; GO:0046677; GO:0048011; GO:0051146; GO:0051384; GO:0051402; GO:0061713; GO:0070059; GO:0071310; GO:0071887; GO:0072734; GO:0097153; GO:0097191; GO:0097193; GO:0097194; GO:0097199; GO:0097200; GO:1902004; GO:1902512; GO:1904019"
"FUN_029410","ME34","ptg000023l:1582755-1585054","P09041","Phosphoglycerate kinase 2 (EC 2.7.2.3) (Phosphoglycerate kinase, testis specific)","Mus musculus (Mouse)","flagellated sperm motility [GO:0030317]; gluconeogenesis [GO:0006094]; glycolytic process [GO:0006096]; phosphorylation [GO:0016310]","GO:0004618; GO:0005524; GO:0005829; GO:0005929; GO:0006094; GO:0006096; GO:0016310; GO:0030317; GO:0035686; GO:0043531"
"FUN_029535","ME12","ptg000023l:3067990-3068845","P45436","Cell death protein 3 (EC 3.4.22.60) (Caspase ced-3) [Cleaved into: Cell death protein 3 subunit p17; Cell death protein 3 subunit p15; Cell death protein 3 subunit p13]","Caenorhabditis remanei (Caenorhabditis vulgaris)","actin filament depolymerization [GO:0030042]; activation of cysteine-type endopeptidase activity [GO:0097202]; apoptotic process involved in development [GO:1902742]; defense response to Gram-negative bacterium [GO:0050829]; embryo development ending in birth or egg hatching [GO:0009792]; muscle cell cellular homeostasis [GO:0046716]; negative regulation of cellular response to manganese ion [GO:1905803]; negative regulation of execution phase of apoptosis [GO:1900118]; positive regulation of apoptotic process involved in development [GO:1904747]; positive regulation of cellular response to gamma radiation [GO:1905845]; positive regulation of neuron apoptotic process [GO:0043525]; positive regulation of oviposition [GO:1901046]; positive regulation of protein processing [GO:0010954]; positive regulation of synapse pruning [GO:1905808]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; regulation of cell adhesion [GO:0030155]; regulation of cell fate specification [GO:0042659]; regulation of development, heterochronic [GO:0040034]; regulation of locomotion [GO:0040012]; regulation of protein stability [GO:0031647]; regulation of vulval development [GO:0040028]","GO:0005739; GO:0008303; GO:0008656; GO:0009792; GO:0010954; GO:0016540; GO:0030042; GO:0030155; GO:0030163; GO:0031647; GO:0031965; GO:0040012; GO:0040028; GO:0040034; GO:0042659; GO:0042802; GO:0043204; GO:0043525; GO:0046716; GO:0048471; GO:0050829; GO:0097200; GO:0097202; GO:0098793; GO:1900118; GO:1901046; GO:1902742; GO:1904747; GO:1905803; GO:1905808; GO:1905845"
"FUN_031877","ME0","ptg000023l:26321283-26336502","O08529","Calpain-2 catalytic subunit (EC 3.4.22.53) (80 kDa M-calpain subunit) (CALP80) (Calcium-activated neutral proteinase 2) (CANP 2) (Calpain M-type) (Calpain-2 large subunit) (Millimolar-calpain) (M-calpain)","Mus musculus (Mouse)","behavioral response to pain [GO:0048266]; blastocyst development [GO:0001824]; cellular response to amino acid stimulus [GO:0071230]; cellular response to interferon-beta [GO:0035458]; cellular response to lipopolysaccharide [GO:0071222]; female pregnancy [GO:0007565]; myoblast fusion [GO:0007520]; positive regulation of cardiac muscle cell apoptotic process [GO:0010666]; positive regulation of myoblast fusion [GO:1901741]; positive regulation of neuron death [GO:1901216]; positive regulation of phosphatidylcholine biosynthetic process [GO:2001247]; protein autoprocessing [GO:0016540]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; proteolysis involved in protein catabolic process [GO:0051603]; regulation of interleukin-6 production [GO:0032675]; response to hydrogen peroxide [GO:0042542]; response to hypoxia [GO:0001666]; response to mechanical stimulus [GO:0009612]","GO:0000785; GO:0001666; GO:0001824; GO:0004198; GO:0005509; GO:0005634; GO:0005737; GO:0005758; GO:0005764; GO:0005783; GO:0005794; GO:0005829; GO:0005886; GO:0005925; GO:0006508; GO:0007520; GO:0007565; GO:0008092; GO:0008233; GO:0009612; GO:0009897; GO:0010666; GO:0016020; GO:0016540; GO:0019899; GO:0030163; GO:0030425; GO:0031143; GO:0032675; GO:0035458; GO:0042542; GO:0042995; GO:0043025; GO:0044877; GO:0045121; GO:0048266; GO:0051603; GO:0071222; GO:0071230; GO:0097038; GO:0110158; GO:1901216; GO:1901741; GO:2001247"
"FUN_032099","ME7","ptg000023l:28831736-28839329","P98192","Dihydroxyacetone phosphate acyltransferase (DAP-AT) (DHAP-AT) (EC 2.3.1.42) (Acyl-CoA:dihydroxyacetonephosphateacyltransferase) (Glycerone-phosphate O-acyltransferase)","Mus musculus (Mouse)","cerebellum morphogenesis [GO:0021587]; ether lipid biosynthetic process [GO:0008611]; fatty acid metabolic process [GO:0006631]; glycerophospholipid metabolic process [GO:0006650]; membrane organization [GO:0061024]; myelination [GO:0042552]; paranodal junction assembly [GO:0030913]; phospholipid biosynthetic process [GO:0008654]; response to fatty acid [GO:0070542]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]; response to xenobiotic stimulus [GO:0009410]; synapse assembly [GO:0007416]","GO:0003824; GO:0005739; GO:0005777; GO:0005778; GO:0005782; GO:0006631; GO:0006650; GO:0007416; GO:0007584; GO:0008611; GO:0008654; GO:0009410; GO:0016287; GO:0021587; GO:0030913; GO:0031966; GO:0042552; GO:0042594; GO:0061024; GO:0070542"
"FUN_032220","ME1","ptg000023l:29856466-29862755","Q19749","Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial (EC 2.3.1.12) (Dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase complex) (Pyruvate dehydrogenase complex component E2) (PDC-E2) (PDCE2)","Caenorhabditis elegans","acetyl-CoA biosynthetic process from pyruvate [GO:0006086]; glycolytic process [GO:0006096]","GO:0004742; GO:0005967; GO:0006086; GO:0006096"
"FUN_033720","ME4","ptg000024l:673513-676224","Q8VDL4","ADP-dependent glucokinase (ADP-GK) (ADPGK) (EC 2.7.1.147)","Mus musculus (Mouse)","carbohydrate metabolic process [GO:0005975]; glucose metabolic process [GO:0006006]; glycolytic process [GO:0006096]","GO:0005576; GO:0005783; GO:0005975; GO:0006006; GO:0006096; GO:0043843; GO:0046872"
"FUN_034834","ME0","ptg000025l:585070-598360","Q3B6R3","ATP-dependent zinc metalloprotease FtsH (EC 3.4.24.-)","Chlorobium luteolum (strain DSM 273 / BCRC 81028 / 2530) (Pelodictyon luteolum)","protein catabolic process [GO:0030163]; proteolysis [GO:0006508]","GO:0004176; GO:0004222; GO:0005524; GO:0005886; GO:0006508; GO:0008270; GO:0016887; GO:0030163"
"FUN_034872","ME3","ptg000025l:1070571-1071703","Q9XTR8","Lipase ZK262.3 (EC 3.1.1.-)","Caenorhabditis elegans","lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0016787"
"FUN_034965","ME0","ptg000025l:2189615-2196599","O75521","Enoyl-CoA delta isomerase 2 (EC 5.3.3.8) (DRS-1) (Delta(3),delta(2)-enoyl-CoA isomerase) (D3,D2-enoyl-CoA isomerase) (Diazepam-binding inhibitor-related protein 1) (DBI-related protein 1) (Dodecenoyl-CoA isomerase) (Hepatocellular carcinoma-associated antigen 88) (Peroxisomal 3,2-trans-enoyl-CoA isomerase) (pECI) (Renal carcinoma antigen NY-REN-1)","Homo sapiens (Human)","fatty acid beta-oxidation [GO:0006635]; fatty acid catabolic process [GO:0009062]; fatty acid metabolic process [GO:0006631]","GO:0000062; GO:0004165; GO:0005739; GO:0005777; GO:0005782; GO:0005829; GO:0006631; GO:0006635; GO:0009062; GO:0016020; GO:0043231"
"FUN_035013","ME0","ptg000025l:2760177-2765085","Q9GV16","Endoglycoceramidase (EGCase) (EC 3.2.1.123) (Glycosphingolipid-specific enzyme) (GSL-specific enzyme)","Cyanea nozakii (Jellyfish)","carbohydrate derivative catabolic process [GO:1901136]; cellulose catabolic process [GO:0030245]; lipid catabolic process [GO:0016042]","GO:0005576; GO:0016042; GO:0030245; GO:0042151; GO:0047876; GO:1901136"
"FUN_035264","ME18","ptg000025l:5797462-5803071","Q16698","2,4-dienoyl-CoA reductase [(3E)-enoyl-CoA-producing], mitochondrial (EC 1.3.1.124) (2,4-dienoyl-CoA reductase [NADPH]) (4-enoyl-CoA reductase [NADPH]) (Short chain dehydrogenase/reductase family 18C member 1)","Homo sapiens (Human)","fatty acid beta-oxidation [GO:0006635]; positive regulation of cold-induced thermogenesis [GO:0120162]","GO:0005634; GO:0005654; GO:0005739; GO:0005759; GO:0005829; GO:0006635; GO:0008670; GO:0042802; GO:0070402; GO:0120162; GO:1902494"
"FUN_035467","ME14","ptg000025l:7690136-7695911","Q16822","Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)","Homo sapiens (Human)","cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; cellular response to tumor necrosis factor [GO:0071356]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; response to lipid [GO:0033993]; response to lipopolysaccharide [GO:0032496]; response to starvation [GO:0042594]","GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032496; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071356; GO:0071549"
"FUN_035468","ME8","ptg000025l:7702781-7707570","Q8BH04","Phosphoenolpyruvate carboxykinase [GTP], mitochondrial (PEPCK-M) (EC 4.1.1.32)","Mus musculus (Mouse)","cellular response to dexamethasone stimulus [GO:0071549]; cellular response to glucose stimulus [GO:0071333]; cellular response to insulin stimulus [GO:0032869]; gluconeogenesis [GO:0006094]; glycerol biosynthetic process from pyruvate [GO:0046327]; hepatocyte differentiation [GO:0070365]; NADH oxidation [GO:0006116]; oxaloacetate metabolic process [GO:0006107]; positive regulation of insulin secretion [GO:0032024]; propionate catabolic process [GO:0019543]; pyruvate metabolic process [GO:0006090]; response to lipid [GO:0033993]; response to starvation [GO:0042594]","GO:0004611; GO:0004613; GO:0005525; GO:0005739; GO:0005759; GO:0005829; GO:0006090; GO:0006094; GO:0006107; GO:0006116; GO:0019543; GO:0030145; GO:0032024; GO:0032869; GO:0033993; GO:0042594; GO:0046327; GO:0070365; GO:0071333; GO:0071549"
"FUN_036246","ME19","ptg000025l:17039450-17057783","P08059","Glucose-6-phosphate isomerase (GPI) (EC 5.3.1.9) (Autocrine motility factor) (AMF) (Neuroleukin) (NLK) (Phosphoglucose isomerase) (PGI) (Phosphohexose isomerase) (PHI)","Sus scrofa (Pig)","erythrocyte homeostasis [GO:0034101]; gluconeogenesis [GO:0006094]; glucose 6-phosphate metabolic process [GO:0051156]; glucose homeostasis [GO:0042593]; glycolytic process [GO:0006096]; in utero embryonic development [GO:0001701]; mesoderm formation [GO:0001707]; positive regulation of endothelial cell migration [GO:0010595]; positive regulation of immunoglobulin production [GO:0002639]","GO:0001701; GO:0001707; GO:0002639; GO:0004347; GO:0005125; GO:0005615; GO:0005654; GO:0005829; GO:0006094; GO:0006096; GO:0010595; GO:0031625; GO:0034101; GO:0042593; GO:0048029; GO:0051156; GO:0060170; GO:0097367"
"FUN_036919","ME13","ptg000026l:3391264-3396308","P13437","3-ketoacyl-CoA thiolase, mitochondrial (EC 2.3.1.16) (Acetyl-CoA acetyltransferase) (EC 2.3.1.9) (Acetyl-CoA acyltransferase) (Acyl-CoA hydrolase, mitochondrial) (EC 3.1.2.-, EC 3.1.2.1, EC 3.1.2.2) (Beta-ketothiolase) (Mitochondrial 3-oxoacyl-CoA thiolase)","Rattus norvegicus (Rat)","acetyl-CoA metabolic process [GO:0006084]; cellular response to hypoxia [GO:0071456]; fatty acid beta-oxidation [GO:0006635]; negative regulation of mitochondrial membrane permeability involved in apoptotic process [GO:1902109]; negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway [GO:1901029]","GO:0003985; GO:0003986; GO:0003988; GO:0005739; GO:0005759; GO:0006084; GO:0006635; GO:0016290; GO:0047617; GO:0071456; GO:0102991; GO:1901029; GO:1902109"
"FUN_037231","ME8","ptg000026l:7335150-7336050","Q920M9","E3 ubiquitin-protein ligase SIAH1 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase SIAH1) (Seven in absentia homolog 1) (Siah-1) (Siah-1a)","Rattus norvegicus (Rat)","canonical Wnt signaling pathway [GO:0060070]; cell differentiation [GO:0030154]; male meiosis I [GO:0007141]; neuron apoptotic process [GO:0051402]; positive regulation of apoptotic process [GO:0043065]; positive regulation of intrinsic apoptotic signaling pathway [GO:2001244]; post-embryonic development [GO:0009791]; proteasome-mediated ubiquitin-dependent protein catabolic process [GO:0043161]; protein catabolic process [GO:0030163]; protein destabilization [GO:0031648]; regulation of multicellular organism growth [GO:0040014]; spermatogenesis [GO:0007283]; ubiquitin-dependent protein catabolic process [GO:0006511]","GO:0004842; GO:0005634; GO:0005737; GO:0005769; GO:0005829; GO:0005886; GO:0006511; GO:0007141; GO:0007283; GO:0008022; GO:0008270; GO:0009791; GO:0019005; GO:0030154; GO:0030163; GO:0030877; GO:0031624; GO:0031648; GO:0040014; GO:0042802; GO:0042803; GO:0043065; GO:0043161; GO:0051402; GO:0060070; GO:0061630; GO:0097718; GO:2001244"
"FUN_037573","ME2","ptg000026l:11925692-11934635","O42586","26S proteasome regulatory subunit 6A-B (26S proteasome AAA-ATPase subunit RPT5-B) (Proteasome 26S subunit ATPase 3-B) (Tat-binding protein 10) (TBP-10)","Xenopus laevis (African clawed frog)","protein catabolic process [GO:0030163]","GO:0005524; GO:0005634; GO:0005737; GO:0016887; GO:0022624; GO:0030163; GO:0036402"
"FUN_038166","ME14","ptg000027l:3306966-3311323","Q7ZX03","Forkhead box protein K2 (FoxK2) (Interleukin enhancer-binding factor 1) (ILF1) (xFoxK1)","Xenopus laevis (African clawed frog)","canonical glycolysis [GO:0061621]; cellular glucose homeostasis [GO:0001678]; negative regulation of autophagy [GO:0010507]; negative regulation of DNA-templated transcription [GO:0045892]; positive regulation of DNA-templated transcription [GO:0045893]; regulation of DNA-templated transcription [GO:0006355]; regulation of glucose metabolic process [GO:0010906]; response to starvation [GO:0042594]","GO:0000287; GO:0000976; GO:0001227; GO:0001678; GO:0003677; GO:0003700; GO:0005634; GO:0005737; GO:0006355; GO:0010507; GO:0010906; GO:0042594; GO:0043565; GO:0045892; GO:0045893; GO:0061621"
"FUN_038464","ME5","ptg000027l:7601510-7607425","Q58DM8","Enoyl-CoA hydratase, mitochondrial (mECH) (mECH1) (EC 4.2.1.17) (EC 5.3.3.8) (Enoyl-CoA hydratase 1) (ECHS1) (Short-chain enoyl-CoA hydratase) (SCEH)","Bos taurus (Bovine)","fatty acid beta-oxidation [GO:0006635]","GO:0004165; GO:0004300; GO:0005739; GO:0005759; GO:0006635; GO:0043956; GO:0120092"
"FUN_038727","ME14","ptg000027l:10634998-10661226","P30566","Adenylosuccinate lyase (ADSL) (ASL) (EC 4.3.2.2) (Adenylosuccinase) (ASase)","Homo sapiens (Human)","'de novo' AMP biosynthetic process [GO:0044208]; 'de novo' IMP biosynthetic process [GO:0006189]; 'de novo' XMP biosynthetic process [GO:0097294]; aerobic respiration [GO:0009060]; AMP biosynthetic process [GO:0006167]; AMP salvage [GO:0044209]; GMP biosynthetic process [GO:0006177]; purine nucleotide biosynthetic process [GO:0006164]; response to hypoxia [GO:0001666]; response to muscle activity [GO:0014850]; response to nutrient [GO:0007584]; response to starvation [GO:0042594]","GO:0001666; GO:0004018; GO:0005829; GO:0006164; GO:0006167; GO:0006177; GO:0006189; GO:0007584; GO:0009060; GO:0014850; GO:0032991; GO:0042594; GO:0042802; GO:0044208; GO:0044209; GO:0070626; GO:0097294"
"FUN_039293","ME2","ptg000028l:389925-395432","P55070","Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (EC 1.2.1.12)","Lactarius deterrimus (False saffron milkcap)","glycolytic process [GO:0006096]","GO:0004365; GO:0005737; GO:0006096; GO:0051287"
"FUN_039818","ME3","ptg000031l:469151-472180","Q6DH69","Fatty-acid amide hydrolase 2-A (EC 3.5.1.99)","Danio rerio (Zebrafish) (Brachydanio rerio)","lipid catabolic process [GO:0016042]","GO:0016020; GO:0016042; GO:0017064"
"FUN_040103","ME8","ptg000031l:4225904-4236045","Q498M4","WD repeat-containing protein 5","Rattus norvegicus (Rat)","gluconeogenesis [GO:0006094]; histone H3 acetylation [GO:0043966]; histone H3-K14 acetylation [GO:0044154]; histone H3-K4 methylation [GO:0051568]; histone H4-K16 acetylation [GO:0043984]; histone H4-K5 acetylation [GO:0043981]; histone H4-K8 acetylation [GO:0043982]; negative regulation of histone H3-K4 methylation [GO:0051572]; neuron projection development [GO:0031175]; peptidyl-lysine methylation [GO:0018022]; positive regulation of gluconeogenesis [GO:0045722]; positive regulation of histone H3-K4 methylation [GO:0051571]; regulation of cell cycle [GO:0051726]; regulation of cell division [GO:0051302]; regulation of DNA-templated transcription [GO:0006355]; regulation of dosage compensation by inactivation of X chromosome [GO:1900095]; regulation of embryonic development [GO:0045995]; regulation of histone deacetylation [GO:0031063]; regulation of transcription by RNA polymerase II [GO:0006357]; regulation of tubulin deacetylation [GO:0090043]; skeletal system development [GO:0001501]; transcription initiation-coupled chromatin remodeling [GO:0045815]","GO:0000123; GO:0001501; GO:0005634; GO:0006094; GO:0006355; GO:0006357; GO:0018022; GO:0031063; GO:0031175; GO:0035064; GO:0035097; GO:0042393; GO:0042800; GO:0043966; GO:0043981; GO:0043982; GO:0043984; GO:0044154; GO:0044545; GO:0044665; GO:0044666; GO:0045722; GO:0045815; GO:0045995; GO:0048188; GO:0051302; GO:0051568; GO:0051571; GO:0051572; GO:0051726; GO:0071339; GO:0090043; GO:0140672; GO:1900095"
"FUN_040116","ME4","ptg000031l:4368735-4375156","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_040244","ME0","ptg000031l:5830990-5836799","P19112","Fructose-1,6-bisphosphatase 1 (FBPase 1) (EC 3.1.3.11) (D-fructose-1,6-bisphosphate 1-phosphohydrolase 1) (Liver FBPase)","Rattus norvegicus (Rat)","carbohydrate metabolic process [GO:0005975]; cellular hyperosmotic salinity response [GO:0071475]; cellular hypotonic salinity response [GO:0071477]; cellular response to cAMP [GO:0071320]; cellular response to insulin stimulus [GO:0032869]; cellular response to magnesium ion [GO:0071286]; cellular response to phorbol 13-acetate 12-myristate [GO:1904628]; cellular response to raffinose [GO:0097403]; cellular response to xenobiotic stimulus [GO:0071466]; dephosphorylation [GO:0016311]; fructose 1,6-bisphosphate metabolic process [GO:0030388]; fructose 6-phosphate metabolic process [GO:0006002]; fructose metabolic process [GO:0006000]; gluconeogenesis [GO:0006094]; negative regulation of cell growth [GO:0030308]; negative regulation of glycolytic process [GO:0045820]; negative regulation of Ras protein signal transduction [GO:0046580]; negative regulation of transcription by RNA polymerase II [GO:0000122]; regulation of gluconeogenesis [GO:0006111]; response to cold [GO:0009409]; response to metformin [GO:1901558]; response to nutrient levels [GO:0031667]; sucrose biosynthetic process [GO:0005986]","GO:0000122; GO:0005615; GO:0005634; GO:0005737; GO:0005829; GO:0005975; GO:0005986; GO:0006000; GO:0006002; GO:0006094; GO:0006111; GO:0009409; GO:0016208; GO:0016311; GO:0030308; GO:0030388; GO:0031667; GO:0032869; GO:0042132; GO:0042802; GO:0045820; GO:0046580; GO:0046872; GO:0048029; GO:0061629; GO:0071286; GO:0071320; GO:0071466; GO:0071475; GO:0071477; GO:0097403; GO:1901558; GO:1904628"
"FUN_040784","ME13","ptg000031l:12653616-12663860","O65201","Acyl-coenzyme A oxidase 2, peroxisomal (AOX 2) (EC 1.3.3.6) (Long-chain acyl-CoA oxidase) (AtCX2)","Arabidopsis thaliana (Mouse-ear cress)","fatty acid beta-oxidation [GO:0006635]; fatty acid beta-oxidation using acyl-CoA oxidase [GO:0033540]; lipid homeostasis [GO:0055088]; long-chain fatty acid metabolic process [GO:0001676]","GO:0001676; GO:0003997; GO:0005504; GO:0005777; GO:0006635; GO:0033540; GO:0050660; GO:0055088; GO:0071949"
"FUN_041710","ME2","ptg000035l:6737981-6752397","Q5LUF3","Propionyl-CoA carboxylase alpha chain (EC 6.4.1.3)","Ruegeria pomeroyi (strain ATCC 700808 / DSM 15171 / DSS-3) (Silicibacter pomeroyi)","lipid catabolic process [GO:0016042]","GO:0004658; GO:0005524; GO:0016042; GO:0046872"
"FUN_041721","ME5","ptg000035l:6790698-6792011","Q5R4G2","Platelet-activating factor acetylhydrolase IB subunit alpha2 (EC 3.1.1.47) (PAF acetylhydrolase 30 kDa subunit) (PAF-AH 30 kDa subunit) (PAF-AH subunit beta) (PAFAH subunit beta)","Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii)","lipid catabolic process [GO:0016042]; positive regulation of macroautophagy [GO:0016239]; spermatogenesis [GO:0007283]","GO:0001650; GO:0003847; GO:0005829; GO:0005886; GO:0007283; GO:0008247; GO:0016042; GO:0016239; GO:0042803; GO:0046982"
"FUN_042618","ME6","ptg000039l:411557-422380","Q6P8U6","Pancreatic triacylglycerol lipase (PL) (PTL) (Pancreatic lipase) (EC 3.1.1.3)","Mus musculus (Mouse)","intestinal cholesterol absorption [GO:0030299]; lipid catabolic process [GO:0016042]; lipid metabolic process [GO:0006629]; positive regulation of triglyceride lipase activity [GO:0061365]; post-embryonic development [GO:0009791]","GO:0004806; GO:0005615; GO:0006629; GO:0009791; GO:0016042; GO:0016298; GO:0030299; GO:0046872; GO:0047376; GO:0061365"
"FUN_042919","ME8","ptg000047l:1772928-1778879","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_042950","ME0","ptg000047l:2301377-2311682","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_042946","ME8","ptg000047l:2205058-2214515","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_042949","ME1","ptg000047l:2251447-2263489","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_042953","ME3","ptg000047l:2366049-2375490","Q12933","TNF receptor-associated factor 2 (EC 2.3.2.27) (E3 ubiquitin-protein ligase TRAF2) (RING-type E3 ubiquitin transferase TRAF2) (Tumor necrosis factor type 2 receptor-associated protein 3)","Homo sapiens (Human)","activation of NF-kappaB-inducing kinase activity [GO:0007250]; cellular response to nitric oxide [GO:0071732]; interleukin-17-mediated signaling pathway [GO:0097400]; intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress [GO:0070059]; mRNA stabilization [GO:0048255]; negative regulation of glial cell apoptotic process [GO:0034351]; negative regulation of neuron death [GO:1901215]; positive regulation of DNA-binding transcription factor activity [GO:0051091]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; positive regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043123]; positive regulation of I-kappaB phosphorylation [GO:1903721]; positive regulation of interleukin-2 production [GO:0032743]; positive regulation of JNK cascade [GO:0046330]; positive regulation of JUN kinase activity [GO:0043507]; positive regulation of NF-kappaB transcription factor activity [GO:0051092]; positive regulation of T cell cytokine production [GO:0002726]; positive regulation of tumor necrosis factor-mediated signaling pathway [GO:1903265]; programmed necrotic cell death [GO:0097300]; protein autoubiquitination [GO:0051865]; protein catabolic process [GO:0030163]; protein K63-linked ubiquitination [GO:0070534]; protein-containing complex assembly [GO:0065003]; regulation of apoptotic process [GO:0042981]; regulation of I-kappaB kinase/NF-kappaB signaling [GO:0043122]; regulation of immunoglobulin production [GO:0002637]; regulation of protein-containing complex assembly [GO:0043254]; response to endoplasmic reticulum stress [GO:0034976]; signal transduction [GO:0007165]; signal transduction involved in regulation of gene expression [GO:0023019]; tumor necrosis factor-mediated signaling pathway [GO:0033209]","GO:0000151; GO:0002637; GO:0002726; GO:0002947; GO:0004842; GO:0005164; GO:0005174; GO:0005654; GO:0005829; GO:0005938; GO:0007165; GO:0007250; GO:0008270; GO:0009898; GO:0012506; GO:0019899; GO:0019901; GO:0019903; GO:0023019; GO:0030163; GO:0030674; GO:0031435; GO:0031625; GO:0031996; GO:0032743; GO:0033209; GO:0034351; GO:0034976; GO:0035631; GO:0042802; GO:0042981; GO:0043120; GO:0043122; GO:0043123; GO:0043254; GO:0043507; GO:0044877; GO:0045121; GO:0046330; GO:0046625; GO:0048255; GO:0051091; GO:0051092; GO:0051865; GO:0065003; GO:0070059; GO:0070534; GO:0071732; GO:0097057; GO:0097300; GO:0097400; GO:1901215; GO:1903265; GO:1903721; GO:1990604; GO:2001238"
"FUN_042982","ME12","ptg000047l:2690313-2698318","Q8BS35","Alkylglycerol monooxygenase (EC 1.14.16.5) (Transmembrane protein 195)","Mus musculus (Mouse)","ether lipid metabolic process [GO:0046485]; lipid biosynthetic process [GO:0008610]; membrane lipid metabolic process [GO:0006643]","GO:0005506; GO:0005783; GO:0005789; GO:0006643; GO:0008610; GO:0046485; GO:0050479"
"FUN_043101","ME8","ptg000047l:4140626-4151051","Q8R4K8","Pappalysin-1 (EC 3.4.24.79) (Insulin-like growth factor-dependent IGF-binding protein 4 protease) (IGF-dependent IGFBP-4 protease) (IGFBP-4ase) (Pregnancy-associated plasma protein A) (PAPP-A)","Mus musculus (Mouse)","cell surface receptor signaling pathway [GO:0007166]; female pregnancy [GO:0007565]; protein catabolic process [GO:0030163]; proteolysis [GO:0006508]; response to dexamethasone [GO:0071548]; response to follicle-stimulating hormone [GO:0032354]","GO:0004175; GO:0004222; GO:0005576; GO:0005615; GO:0006508; GO:0007166; GO:0007565; GO:0008237; GO:0030163; GO:0032354; GO:0046872; GO:0071548"
"FUN_043244","ME18","ptg000047l:5890218-5894415","Q5ZJF4","Peroxiredoxin-6 (EC 1.11.1.27) (1-Cys peroxiredoxin) (1-Cys PRX) (Acidic calcium-independent phospholipase A2) (aiPLA2) (EC 3.1.1.4) (Glutathione-dependent peroxiredoxin) (Lysophosphatidylcholine acyltransferase 5) (LPC acyltransferase 5) (LPCAT-5) (Lyso-PC acyltransferase 5) (EC 2.3.1.23) (Non-selenium glutathione peroxidase) (NSGPx)","Gallus gallus (Chicken)","cell redox homeostasis [GO:0045454]; lipid catabolic process [GO:0016042]","GO:0004623; GO:0005615; GO:0005739; GO:0005764; GO:0005829; GO:0016042; GO:0045454; GO:0047184; GO:0051920"
